AgenDx Biosciences Company
AgenDx is an early stage molecular diagnostics company develops a revolutionary cost-effective molecular diagnostics platform.
Founded Date:
01.01.2014
Industry:
Deep Diagnostics
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Debt
Total Funding:
$39.4M
Headquarters:
South Bend, Indiana, United States
Technology:
Genetic Test & Molecular Diagnostics
Investor Type:
For Profit
Investors Number:
2
Employee Number:
1-10
Funding Status:
Seed